Five Prime Therapeutics Inc
Anti-CSF1R Antibodies for Treating PVNS
Last updated:
Abstract:
Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.
Status:
Application
Type:
Utility
Filling date:
25 Jun 2020
Issue date:
14 Jan 2021